@article{6c6c1fc65bcb42ceba331100126e8819,
title = "Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife",
abstract = "Introduction: World Trade Center (WTC) responders who aided in the search and rescue efforts are now at midlife, and evidence has demonstrated that many are experiencing early-onset cognitive impairment and are at risk of developing dementia, such as Alzheimer{\textquoteright}s disease (AD). According to the recent NIA-AA framework, AD is characterized by a neuropathological cascade commencing with β-amyloid deposition (A), followed by tauopathy (T) and neurodegeneration (N). However, the ATN model has not been replicated utilizing recently validated plasma-based biomarkers, and the role of the Aβ40 subtype in A is not well understood. This study examined plasma-based neuropathological markers of Aβ42 and Aβ40 for A, total tau for T, and NfL for N in a cohort of World Trade Center responders at midlife in order to determine the role for the two β-amyloid subtypes in the ATN model. Methods: Ultrasensitive Simoa technology was utilized to measure neuropathology in plasma collected from a consecutive clinical sample (n =398). Generalized structural equation modeling was utilized for modeling linkages between pathological markers. Model fit was utilized to determine proposed directions of association. Results: Our findings support the ATN neuropathological cascade model of AD and further identify an associative role for Aβ40 in A as playing a central role linking T to N. A strong correlation was found between CI and age, and it was found that women may be at increased risk of elevated T levels, with plasma NfL levels higher in responders with CI. Notably, our model reported associations between: Aβ42, CI and N; Aβ40, T and N; T and CI; Aβ42 and Aβ40. Conclusions: The current ATN model of AD does not specify the subtype of β-amyloid to be considered, which may be overlooking the differential roles that these two subtypes serve in the pathogenesis of AD.",
keywords = "ATN, Alzheimer{\textquoteright}s disease, Cognitive impairment, Dementia, Neurofilament light, Pathway analysis, Plasma, Tau, World Trade Center, β-Amyloid",
author = "Minos Kritikos and Clouston, {Sean A.P.} and Diminich, {Erica D.} and Yael Deri and Xiaohua Yang and Melissa Carr and Sam Gandy and Mary Sano and Bromet, {Evelyn J.} and Luft, {Benjamin J.}",
note = "Funding Information: We would also like to acknowledge the support for aging-related research in this population (NIH/NIA R01 049953), and for funding to support brain aging research and treatment (NIH/NIA P50 AG005138). Funding Information: The authors would like to acknowledge the support from the National Institute for Occupational Safety and Health (NIOSH), who support World Trade Center clinical and monitoring efforts at Stony Brook University (CDC/NIOSH 200-2011-39361). Finally, we would like to kindly thank all WTC responders who participated in this study. We would also like to acknowledge the support for aging-related research in this population (NIH/NIA R01 049953), and for funding to support brain aging research and treatment (NIH/NIA P50 AG005138). All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Minos Kritikos, Sean A. P. Clouston, Erica D. Diminich, Yael Deri, Xiaohua Yang, Melissa Carr, Sam Gandy, Mary Sano, Evelyn J. Bromet and Benjamin J. Luft have nothing to disclose. The present study received approval from the Stony Brook Institutional Review Board (IRB, CORIHS #604113). All participants provided written informed consent, and the study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. Funding Information: The authors would like to acknowledge the support from the National Institute for Occupational Safety and Health (NIOSH), who support World Trade Center clinical and monitoring efforts at Stony Brook University (CDC/NIOSH 200-2011-39361). Finally, we would like to kindly thank all WTC responders who participated in this study. Publisher Copyright: {\textcopyright} 2020, The Author(s).",
year = "2020",
month = jun,
day = "1",
doi = "10.1007/s40120-020-00189-1",
language = "English",
volume = "9",
pages = "159--171",
journal = "Neurology and Therapy",
issn = "2193-8253",
publisher = "Springer Healthcare",
number = "1",
}